Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide plus insulin pump in poorly controlled type 2 diabetes
ChiCTR1900024828Phase 4Recruiting
- Sponsor
- Xuzhou Traditional Chinese Medicine Hospital
- Start
- Mar 2019
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of liraglutide and human insulin in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Xuzhou Traditional Chinese Medicine Hospital. Primary endpoints: Fasting blood glucose, Postprandial blood glucose and 3 more. Started Mar 2019; status: recruiting.
02
Drugs
liraglutidehuman insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ChiCTR1900024828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024828.